|
Sarcoidosis before and after treatment: cardiac catheterization data |
|||
| January |
March |
September |
|
|
|
|||
| 2002 |
2003 |
2006 |
|
|
|
|||
| PAP systolic (mmHg) |
60 |
42 |
37 |
| PAP mean (mmHg) |
36.7 |
24 |
19 |
| CO (l/min) |
7.8 |
10.2 |
6.9 |
| PVR (dyn·s/cm5) |
253 |
125 |
151 |
| Bosentan dose (mg) |
0 |
125 |
125 |
| twice daily |
twice daily |
||
|
Shown are pretreatment and post-treatment cardiac catheterization data in a patient with steroid-refractory sarcoidosis who was treated with bosentan and infliximab. CO, cardiac output; PAP, pulmonary artery pressure; PVR, pulmonary vascular resistance. | |||
Baughman Arthritis Research & Therapy 2007 9(Suppl 2):S8 doi:10.1186/ar2192 |
|||